
UiPath carried annualized renewal run-rate of $1,937.7 million at 31 July 2026, and its quarterly report for that period defines the metric as annualized invoiced amounts per solution SKU. That's an invoiced figure, and the company tells investors to read it independently of revenue and to avoid leaning on it as a guide to future results.
The trap is treating that number as revenue the company will book. Its fiscal year ends 31 January, so the $1,610.572 million revenue line belongs to the twelve months ended 31 January 2026, while the ARR reading is a point in time six months later. Phemex listed the PATH perpetual at 10:00 UTC on 20 September 2026, and it holds one bar.
UiPath (PATH) at a Glance
|
Item
|
Detail
|
|
What UiPath sells
|
Software robots running rule-based tasks
|
|
What ARR measures
|
Invoiced amounts per SKU, annualized
|
|
ARR against the year to 31 January 2026
|
$1,937.7M against $1,610.572M
|
|
The two growth rates
|
ARR +12.4%, revenue +13.4%
|
|
Fiscal year end
|
31 January, not December
|
|
Where it trades
|
PATHUSDT, Listed 20 September 2026
|
What Is UiPath (PATH) and What Does It Sell?
What UiPath sells is automation software, and UiPath stock trades on the New York Stock Exchange under the PATH ticker. The company started in Bucharest in 2005 and incorporated in Delaware in 2015. Its annual report calls the original product computer vision and user interface automation, the foundation the platform still rests on. In the company's own words that platform runs "software robots that can perform rule-based tasks across desktop and web applications". API automation and AI agents that plan and execute run alongside those robots. Strip the branding off and you have robotic process automation with an agent layer on top.
The revenue mix says which half pays the bills. For the three months ended 31 July 2026 subscription services brought in $266.067 million against $123.843 million of licences and $20.346 million of professional services. Licences are a term product the company books when the customer can use the software, and they carried 30 percent of the quarter. UiPath employed 3,981 full-time staff at 31 January 2026. Phemex lists the PATH ticker as a perpetual, which puts a New York Stock Exchange name beside tokenized stocks and the products that copy them.
What UiPath ARR Actually Measures
ARR stands for annualized renewal run-rate, and the definition does the work here. UiPath takes the invoiced amount per solution SKU under a subscription licence or maintenance agreement at the end of an invoiced period, divides it by the term and multiplies by 365 days. Nothing in that calculation waits for software to reach a customer. The filing puts the limit in one line. "ARR is not a forecast of future revenue."
Two more sentences in the same section tell you how much weight to put on it. "Investors should not place undue reliance on ARR as an indicator of our future or expected results", the 10-Q reads, and it adds that UiPath's presentation of the metric may differ from similarly titled metrics at other companies. Read UiPath ARR as a billing run-rate and you're reading it the way the issuer describes it.
Set it against the contracted work and a gap opens. Remaining performance obligations at 31 July 2026 came to $1,377.6 million, split between $615.4 million billed and $762.2 million unbilled. ARR prints $560.1 million above everything UiPath has contracted and not yet delivered. A backlog figure can't behave that way, and ARR isn't a backlog figure.
Why UiPath ARR Growth Trails UiPath Revenue Growth
A leading metric should run ahead of the thing it leads. UiPath's does the opposite. ARR went from $1,723.401 million at 31 July 2025 to $1,937.722 million a year later, a gain of 12.4 percent. Revenue for the quarter ended 31 July 2026 came to $410.256 million against $361.728 million, a gain of 13.4 percent. The 10-Q rounds those two to 12 percent and 13 percent.
The reason is in the revenue line. A multi-year deal invoiced upfront lands as revenue when the customer can use the licence, and it lands in ARR at the annualized rate of its final year. Timing of billing moves ARR, and timing of delivery moves revenue. Those two clocks run at different speeds, and over the twelve months to 31 July 2026 the delivery clock ran faster.
Incremental ARR still grew.
UiPath added $214.321 million of it over that year against $172.796 million the year before, and customers paying $1 million or more went from 320 to 387. The business expanded. The metric carrying its name expanded more slowly than the revenue it exists to predict.
The Fiscal Calendar Behind Every UiPath Revenue Figure
UiPath closes its books on 31 January, so a fiscal 2026 figure covers February 2025 through January 2026. The 10-Q states it plainly. "Our fiscal year ends on January 31." Anyone lining UiPath up against a December-year company is overlapping two calendars that miss each other by a month at both ends.
Revenue for the year ended 31 January 2026 came to $1,610.572 million. Put the July ARR reading beside it and the ratio comes out at 1.20 times. Those two readings are six months apart. Run the same ratio against trailing twelve-month revenue to 31 July 2026, which comes to $1,720.858 million, and it falls to 1.13 times. Name the period beside the ratio or the ratio tells you nothing.
Half of fiscal 2027 is already filed. Revenue for the six months to 31 July 2026 reached $828.638 million, and the company turned an operating loss of $36.597 million a year earlier into operating income of $59.591 million. That swing matters to anyone holding the ticker through a traditional-finance futures contract on a crypto venue.
What UiPath Says About AI in Its Own Risk Factors
The 10-Q filed 8 September 2026 reports no material changes to the risk factors in the annual report of 25 March 2026, so the annual report holds the AI language. One sentence in it does the job. "Other companies may incorporate AI into their products more quickly or more successfully than us, or AI technology for code generation or application development could reduce demand for our platform, which could impair our ability to compete effectively and adversely affect our financial results."
That's the company naming the thing that can eat its own product. The competition section of the same report lists proprietary and open-source AI model providers and coding agents among its rivals, alongside enterprise platform vendors building automation into their own stacks. UiPath's answer has been to buy. It paid $189.5 million for WorkFusion on 5 February 2026, $160.0 million of that in cash, for AI agents aimed at financial-crime compliance.
The spend shows up beside a cut. Research and development fell to $83.393 million in the quarter from $98.341 million a year earlier, and gross margin came in at 80 percent against 82 percent. The company points at third-party subcontractor costs in professional services for part of that margin move. Revenue growth and margin pressure are both true readings of the same three months.
How the PATH Perpetual Futures Contract Trades on Phemex
PATHUSDT went live on Phemex at 10:00 UTC on 20 September 2026 at a maximum of 10x, with funding every 28,800 seconds at 00:00, 08:00 and 16:00 UTC. One contract covers one PATH and settles in USDT. The PATH perpetual futures contract is a derivative with no expiry date, and it is never the share itself.
The whole history is one bar. It opened at $13.65 on 20 September 2026 and closed at $13.56, with a high of $13.65 and a low of $13.49. That's a fall of 0.66 percent open to close, on a bar running 14 hours and not a full day. No 20-day, 50-day or 200-day average exists on this contract, so anyone quoting one has invented it.
The turnover column tells you what size this book can take. PATHUSDT moved $4,817 of value across that bar. The seven US stock perpetuals that listed together turned over $126,967 between them, so PATH took 3.8 percent of a very small pot. An order that disappears into a Bitcoin book moves this one, and the pre-market perpetual futures guidecovers what a thin book does to a fill.
The listing landed on a Sunday, with the US cash market shut. That mark has no session of the underlying behind it, which makes the 20 September close a weekend print and not a closing price for PATH stock. A stock perpetual quoted while its cash market is shut behaves the same way.
Frequently Asked Questions
What is UiPath's dollar-based net retention rate?
109 percent at 31 July 2026, against 108 percent a year earlier. It measures net expansion of ARR from existing customers over the prior twelve months and leaves out ARR from new customers.
How many customers pay UiPath $100,000 or more a year?
2,666 at 31 July 2026, up from 2,432. Those accounts produced 88 percent of the quarter's revenue, against 87 percent a year earlier.
How much cash does UiPath hold?
Cash, restricted cash and marketable securities came to $1,406.5 million at 31 July 2026, down from $1,689.9 million at 31 January 2026. The company bought back 22.8 million Class A shares at an average of $11.28 over the six months to 31 July 2026.
Where does UiPath revenue come from geographically?
The Americas produced 50 percent of the three months to 31 July 2026, and the United States alone produced 44 percent. Europe, the Middle East and Africa added 33 percent, with Asia-Pacific at 17 percent.
Does Phemex list a UiPath spot market?
No. The product file carries PATHUSDT as a perpetual only, so that contract is the single route to a position on this ticker there.
Bottom Line
Read the metric's name and you've read the caveat. Annualized renewal run-rate counts what a customer got invoiced, scaled to a year, and the issuer says outright that nobody should lean on it as an indicator of results. The number it claims to lead grew slower than that number did over the twelve months to 31 July 2026. Price a $1.94 billion headline into a contract that moved $4,817 on its first bar and you are paying for a label.
Disclaimer: This article is for informational purposes only and is not financial advice. Cryptocurrency trading involves substantial risk. Always do your own research before making investment decisions.
